Review: Senescent bone cells and their inflammatory signals in age-related bone loss
This abstract reviews how senescent bone cells release inflammatory and other factors (the SASP) that feed into the same bone-remodeling pathways as classical triggers, and how senolytic and senomorphic approaches compare with established osteoporosis treatments. [1]
Automatic summary · not editorially reviewed
The key findings
In the ageing bone microenvironment, senescent osteocytes, mesenchymal stem cells, osteoblasts, immune cells and vascular endothelial cells secrete pro-inflammatory cytokines, chemokines, matrix metalloproteinases and Wnt antagonists such as sclerostin. [1]
The SASP factors converge on the same RANKL/OPG, Wnt/β-catenin and NF-κB axes as classical triggers, adding a persistent local input that promotes resorption and suppresses formation. [1]
Clearance of senescent cells prevents age-related bone loss in mice, which the abstract presents as evidence that the SASP is a distinct and independently addressable contributor to skeletal ageing. [1]
The source at a glance
- Study type / format
- Review (abstract only)
- Population / context
- Cells of the ageing bone microenvironment and people with age-related, postmenopausal or secondary osteoporosis, as described in the abstract
- Summary based on
- Study abstract
- Original publication
- September 22, 2026
Senescent bone cells and their secreted factors
The abstract describes the ageing bone microenvironment, in which senescent osteocytes, mesenchymal stem cells, osteoblasts, immune cells and vascular endothelial cells secrete pro-inflammatory cytokines, chemokines, matrix metalloproteinases and Wnt antagonists such as sclerostin. These secreted factors are collectively called the senescence-associated secretory phenotype, or SASP.
Supporting source [1]
How the SASP converges on remodeling pathways
According to the abstract, the SASP does not act as a separate parallel pathway. Its factors converge on the same RANKL/OPG, Wnt/β-catenin and NF-κB axes through which classical triggers operate, adding a locally generated, persistent input that promotes bone resorption and suppresses bone formation.
Supporting source [1]
Mouse clearance finding and review scope
The abstract states that clearing senescent cells prevents age-related bone loss in mice, which it presents as evidence that the SASP is a distinct and independently addressable contributor to skeletal ageing. The review covers the components, regulation and cell-type-specific profiles of the bone-related SASP and its differential involvement across age-related, postmenopausal and secondary osteoporosis. It also assesses senolytic and senomorphic approaches relative to established osteoporosis treatments, naming source-specific mechanisms, biomarker validation and longer-term skeletal outcomes as priorities.
Supporting source [1]
How to interpret this
This is an abstract only; the full text was not reviewed. The mouse clearance finding is preclinical and does not establish human benefit. Senolytic and senomorphic approaches are discussed as priorities for evaluation, not as validated treatments.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Liu H, Lei B. · europepmc.org · September 22, 2026